Long-term progestin use increased the risk of developing meningioma
A case-control study by French scientists found that long-term use of medrogestone, medroxyprogesterone and promegestone, which are used as contraception and therapy for gynecologic diseases and breast neoplasms, increases the risk of developing intracranial meningioma
28.03.2024